Suzetrigine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01-25 in 4mo
ESTIMATED |
READOUT
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Par
Phase 3 · Diabetic Peripheral Neuropathic Pain |
Vertex Pharmaceuticals Incorporate | Suzetrigine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
|